| Catalog Number |
ES2920 |
| Medical Device Problem Code |
Fracture (1260)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/06/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The lot number was reviewed for complaint trend, nonconforming report and capa.Devices met specification prior to release.No trends were noted for complaints and there were no nonconforming reports or capas that were confirmed to be associated.The device was not returned for evaluation.Without the benefit of analyzing the device, quality cannot comment on the condition of the device.Should additional information prompt us to alter or supplement any information or conclusions contained in this report, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
According to the available information, implant removed and replaced due to a tubing break by pump.
|
| |
|
Event or Problem Description
|
|
According to the available information, implant removed and replaced due to a tubing break by pump.
|
| |
|
Additional Manufacturer Narrative
|
|
Titan touch pump and cylinders 1 and 2 were received for evaluation.Abrasion was noted on both exhaust tubes and the inlet tube of the pump.No functional abnormalities were noted with the pump.A group of striations, indicating contact with unshod instrumentation, was noted on the bladders of cylinder 1 and cylinder 2.This is a site of leakage.A separation surrounded by abrasion was noted on the tubing of cylinder 1 near the strain relief.This is a site of leakage.Based on examination of the returned product, it was concluded that while in-vivo both the exhaust tubes and inlet tube of the pump had overlapped and abraded against one another.This position, in combination with device usage of time, could contribute to sufficient stress to separate the exhaust tubing of cylinder 1 at the strain relief junction.A separation of this type could then allow the loss of fluid, making the device inoperable.Because these components were released according to manufacturing and quality control procedures, it was concluded that the observed instrument separation in the bladders of cylinder 1 and cylinder 2 occurred after the device packaging was opened.In addition, because the expected use of this device combined with the observed separations would have resulted in earlier detected fluid loss, it was concluded that the separations most likely occurred during or after explant.This separation is not associated with the cause for failure.A review of the device history record confirmed the devices from this lot met all specifications prior to release.A review of the complaint history database, nonconformances, and capas revealed no trends for this lot.
|
| |
|
Search Alerts/Recalls
|